Literature DB >> 3348770

Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I.

M Ernst1, E R Froesch.   

Abstract

Gene-recombinant human growth hormone (rhGH) elicited a dose-dependent stimulation of the proliferation of osteoblast-like cells (OB), when grown in strictly serum-free longterm cultures. A half-maximal effect was observed at concentrations of 15-20 ng/ml and the maximal stimulation was 160% of hormone-free controls. The rhGH-induced effect on proliferation could be inhibited dose-dependently by the addition of an insulin-like growth factor (IGF) I-antiserum to the medium. Moreover, IGF I and rhGH had additive effects only when the exogenous IGF I concentration exceeded that of endogenously produced IGF I by a large margin. Thus, direct stimulation of OB proliferation by rhGH is, at least in part, mediated by IGF I-like immunoreactivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348770     DOI: 10.1016/0006-291x(88)90570-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Factors that affect postnatal bone growth retardation in the twitcher murine model of Krabbe disease.

Authors:  Miguel Agustin Contreras; William Louis Ries; Srinivasan Shanmugarajan; Gonzalo Arboleda; Inderjit Singh; Avtar Kaur Singh
Journal:  Biochim Biophys Acta       Date:  2010-05-02

Review 2.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

Review 3.  Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential.

Authors:  Z Laron
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

4.  The regulation of L-proline transport by insulin-like growth factor-I in human osteoblast-like SaOS-2 cells.

Authors:  Y Kudo; M Iwashita; T Iguchi; Y Takeda
Journal:  Pflugers Arch       Date:  1996-07       Impact factor: 3.657

5.  Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency.

Authors:  A Sartorio; S Ortolani; A Conti; R Cherubini; E Galbiati; G Faglia
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

6.  New markers of bone and collagen turnover in children and adults with growth hormone deficiency.

Authors:  A Sartorio; A Conti; M Monzani
Journal:  Postgrad Med J       Date:  1993-11       Impact factor: 2.401

7.  Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro.

Authors:  M Kassem; W Blum; J Ristelli; L Mosekilde; E F Eriksen
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

8.  Growth hormone involvement in the regulation of tartrate-resistant acid phosphatase-positive cells that are active in cartilage and bone resorption.

Authors:  D Lewinson; P Shenzer; Z Hochberg
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

9.  Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats.

Authors:  F Sato; Y Ouchi; A Masuyama; T Nakamura; T Hosoi; Y Okamoto; N Sasaki; M Shiraki; H Orimo
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

10.  Expression of growth hormone receptor by immunocytochemistry in rat molar root formation and alveolar bone remodeling.

Authors:  C Z Zhang; W G Young; H Li; A M Clayden; J Garcia-Aragon; M J Waters
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.